{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:09:26Z","timestamp":1762916966445},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T00:00:00Z","timestamp":1116288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,15]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The aim of this study was to identify immunoreactive domains on human ribosomal P0, P1 and P2 proteins, other than the C-22 peptide, to develop a novel ELISA using a combination of these proteins and to compare this ELISA with one using the C-22 peptide. Human recombinant P0, P1, P2 and mutant P0 lacking the homologous C-22 peptide (N-P0) were produced in bacteria and tested by ELISA and immunoblotting using sera from 48 patients with systemic lupus erythematosus (SLE), 48 with an unrelated inflammatory disorder (Crohn's disease) and 47 healthy controls. ELISA with P0, P1 and P2, premixed at equimolar concentrations, gave higher OD readings than each protein tested individually. Eighteen SLE sera tested positive by ELISA with premixed P0, P1, P2 but only 3 tested positive with the C-22 peptide. Twenty-two SLE sera reacted positively, as determined by immunoblotting, with 5 different P protein combinations: P1P2, P0P1P2, P1, P0P1, P0 and P1. Only sera reactive with all three P proteins reacted with the C-22 peptide, with absent or minimal reactivity with N-P0. Native antigens yielded sensitivity (6\/48, 13%) similar to the C-22 peptide assay. An ELISA with premixed P1 and P2 gave higher OD values than the arithmetic means with P1 or P2. Fifteen SLE patients had antibodies to double stranded (ds)-DNA, of which 6 also had antibodies to P0P1P2 by ELISA but 12 reactive with P0P1P2 did not have discernable ds-DNA antibodies. Ribosomal P autoantibodies react mainly with epitopes N-terminal to a homologous C-22 peptide. An ELISA with premixed P0, P1 and P2 has 5-fold greater sensitivity (38%) for SLE than an assay with the conventional C-22 peptide (7%). The combined sensitivity for SLE for antibodies to P0P1P2 and ds-DNA is 56%, higher than C-22 and ds-DNA, 38%. Only one of the SLE patients had neuropsychiatric lupus.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02816.x","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T12:33:14Z","timestamp":1118838794000},"page":"155-164","source":"Crossref","is-referenced-by-count":19,"title":["Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus"],"prefix":"10.1093","volume":"141","author":[{"given":"J L J","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Immunology, Monash Medical School, the Alfred Hospital, Prahran, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Dubljevic","sequence":"additional","affiliation":[{"name":"Department of Immunology, Monash Medical School, the Alfred Hospital, Prahran, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Fritzler","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ban-Hock","family":"Toh","sequence":"additional","affiliation":[{"name":"Department of Immunology, Monash Medical School, the Alfred Hospital, Prahran, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,17]]},"reference":[{"key":"2022010817003753100_b1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jaut.2002.0595","article-title":"Diagnostic tests for antiribosomal, p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays","volume":"19","author":"Ghirardello","year":"2002","journal-title":"J Autoimmun"},{"key":"2022010817003753100_b2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","article-title":"Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients","volume":"41","author":"Gerli","year":"2002","journal-title":"Rheumatology"},{"key":"2022010817003753100_b3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcla.20026","article-title":"Technical and clinical evaluation of anti-ribosomal P protein immunoassays","volume":"18","author":"Mahler","year":"2004","journal-title":"J Clin Laboratory Anal"},{"key":"2022010817003753100_b4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rheumatology\/36.2.229","article-title":"Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients","volume":"36","author":"Isenberg","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2022010817003753100_b5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/0891693021000045714","article-title":"Autoantibodies directed against ribosomal proteins in systemic lupus erythematosus and rheumatoid arthritis: a comparative study","volume":"35","author":"Desbos","year":"2002","journal-title":"Autoimmunity"},{"key":"2022010817003753100_b6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/rheumatology\/32.8.663","article-title":"Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus","volume":"32","author":"Teh","year":"1993","journal-title":"Br J Rheumatol"},{"key":"2022010817003753100_b7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.1780391109","article-title":"Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J","article-title":"Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease","volume":"42","author":"Reichlin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b9","first-page":"1681","article-title":"Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease","volume":"18","author":"Sato","year":"1991","journal-title":"J Rheumatol"},{"key":"2022010817003753100_b10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/096120339600500106","article-title":"Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE","volume":"5","author":"Martin","year":"1996","journal-title":"Lupus"},{"key":"2022010817003753100_b11","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(199912)42:12<2728::AID-ANR34>3.0.CO;2-M","article-title":"Evidence for the participation of anti-ribosomal P antibodies in lupus nephritis","volume":"42","author":"Reichlin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1521-6616(03)00063-9","article-title":"Correlations of anti-ds-DNA and anti-ribosomal P autoantibodies with lupus nephritis","volume":"108","author":"Reichlin","year":"2003","journal-title":"Clin Immunol"},{"key":"2022010817003753100_b13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.1780360917","article-title":"Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus","volume":"36","author":"Koren","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0002-9343(99)80221-6","article-title":"Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P","volume":"99","author":"Arnett","year":"1995","journal-title":"Am J Med"},{"key":"2022010817003753100_b15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N Eng J Med"},{"key":"2022010817003753100_b16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780390420","article-title":"Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis","volume":"39","author":"Press","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb48399.x","article-title":"(1997). Anti-P antibodies and neuropsychiatric lupus erythematosus","volume":"823","author":"Georgescu","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"2022010817003753100_b18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1191\/0961203303lu502oa","article-title":"Ribosomal P antibodies and CNS lupus","volume":"12","author":"Reichlin","year":"2003","journal-title":"Lupus"},{"key":"2022010817003753100_b19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08916930290016547","article-title":"Autoantibodies in neuropsychiatric lupus","volume":"35","author":"Greenwood","year":"2002","journal-title":"Autoimmunity"},{"key":"2022010817003753100_b20","doi-asserted-by":"crossref","first-page":"19762","DOI":"10.1074\/jbc.M101398200","article-title":"Pivotal role of the P1 N-terminal domain in the assembly of the mammalian ribosomal stalk and in the proteosynthetic activity","volume":"276","author":"Gonzalo","year":"2001","journal-title":"J Biol Chem"},{"key":"2022010817003753100_b21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0248-4900(03)00034-0","article-title":"The puzzling lateral flexible stalk of the ribosome","volume":"95","author":"Gonzalo","year":"2003","journal-title":"Biol Cell"},{"key":"2022010817003753100_b22","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/nar\/gkf379","article-title":"(2002). Interaction among silkworm ribosomal proteins P1, P2 and P0 required for functional protein binding to the GTPase-associated domain of 28S rRNA","volume":"30","author":"Shimizu","year":"2002","journal-title":"Nucl Acids Res"},{"key":"2022010817003753100_b23","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1074\/jbc.M107730200","article-title":"Translation elongation by a hybrid ribosome in which proteins at the GTPase center of the Escherichia coli ribosome are replaced with rat counterparts","volume":"277","author":"Uchiumi","year":"2002","journal-title":"J Biol Chem"},{"key":"2022010817003753100_b24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2249.1994.tb06603.x","article-title":"Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain","volume":"98","author":"Sato","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2022010817003753100_b25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/clin.1994.1141","article-title":"The effect of phosphorylation and site-specific mutations in the immunodominant epitope of the human ribosomal P proteins","volume":"72","author":"Hasler","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"2022010817003753100_b26","first-page":"771","article-title":"Detection of anti-ribosome antibodies: a long story of lights and shadows","volume":"21","author":"Caponi","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2022010817003753100_b27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1172\/JCI117328","article-title":"Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus","volume":"94","author":"Crow","year":"1994","journal-title":"J Clin Invest"},{"key":"2022010817003753100_b28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0003-9861(88)90045-8","article-title":"The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients","volume":"267","author":"Stacey","year":"1988","journal-title":"Arch Biochem Biophy"},{"key":"2022010817003753100_b29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI115707","article-title":"Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells","volume":"89","author":"Koren","year":"1992","journal-title":"J Clin Invest"},{"key":"2022010817003753100_b30","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.159.4.2033","article-title":"Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture","volume":"159","author":"Koscec","year":"1997","journal-title":"J Immunol"},{"key":"2022010817003753100_b31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.162.2.459","article-title":"Lupus autoantibodies target ribosomal P proteins","volume":"162","author":"Elkon","year":"1985","journal-title":"J Exp Med"},{"key":"2022010817003753100_b32","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1073\/pnas.83.19.7419","article-title":"Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus","volume":"83","author":"Elkon","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010817003753100_b33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/art.1780290806","article-title":"Clinical and serological associations of the anti-ribosomal P protein antibody","volume":"29","author":"Bonfa","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus pyschosis and anti-ribosomal antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"New Eng J Med"},{"key":"2022010817003753100_b35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.59.2.99","article-title":"The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease","volume":"59","author":"Tzioufas","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2022010817003753100_b36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00109-003-0423-1","article-title":"Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins","volume":"81","author":"Mahler","year":"2003","journal-title":"J Mol Med"},{"key":"2022010817003753100_b37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(94)00285-5","article-title":"Autoantibodies directed against ribosomal P proteins: use \u200aof \u200aa \u200amultiple \u200aantigen \u200apeptide \u200aas \u200athe \u200acoating \u200aagent \u200ain \u200aELISA","volume":"179","author":"Caponi","year":"1995","journal-title":"J Immunol Meth"},{"key":"2022010817003753100_b38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2022010817003753100_b39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"2022010817003753100_b40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1749-6632.1975.tb29197.x","article-title":"Crithidia luciliae, a simple substrate for the determination of anti-ds-DNA with the immunofluorescence techniquE.","volume":"254","author":"Aarden","year":"1975","journal-title":"Ann N Y Acad Sci"},{"key":"2022010817003753100_b41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jaut.1999.0291","article-title":"Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins","volume":"13","author":"Fabien","year":"1999","journal-title":"J Autoimmun"},{"key":"2022010817003753100_b42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9258(19)40199-3","article-title":"Monoclonal antibodies against acidic phosphoproteins P0, P1 and P2 of eukaryotic ribosomes as functional probes","volume":"265","author":"Uchiumi","year":"1990","journal-title":"J Biol Chem"},{"key":"2022010817003753100_b43","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.4049\/jimmunol.146.10.3386","article-title":"Anti-P autoantibody production requires P1\/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice","volume":"146","author":"Hines","year":"1991","journal-title":"J Immunol"},{"key":"2022010817003753100_b44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s000180300050","article-title":"Recombinant anti-P protein autoantibodies isolated from a human autoimmune library. reactivity, specificity and epitope recognition","volume":"60","author":"Zampieri","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"2022010817003753100_b45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bbrc.2004.07.196","article-title":"Baculovirus-mediated expression and isolation of human ribosomal phosphoprotein P0 carrying a GST-tag in a functional state","volume":"322","author":"Abo","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02816.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/141\/1\/155\/42080511\/j.1365-2249.2005.02816.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/141\/1\/155\/42080511\/j.1365-2249.2005.02816.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:34:44Z","timestamp":1683113684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/141\/1\/155\/6440470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,5,17]]},"published-print":{"date-parts":[[2005,6,15]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02816.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7]]},"published":{"date-parts":[[2005,5,17]]}}}